首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form
Authors:Gisella Figlioli  Stefano Landi  Cristina Romei  Rossella Elisei  Federica Gemignani
Institution:1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui 230032, China;2. Department of Head and Neck, Breast Surgery, Anhui Provincial Cancer Hospital (West Branch of The First Affiliated Hospital of University of Science and Technology of China), Hefei, Anhui 230088, China;3. Central Laboratory of Preventive Medicine, School of Public Health, Anhui Medical University, Hefei, Anhui 230032, China;1. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, King Saud University, Riyadh 12629, Saudi Arabia;2. Li Ka Shing Knowledge Institute of St Michael''s Hospital, Toronto, Ontario, M5B 1T8, Canada;3. Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, L8S 4K1, Canada;4. Division of Geriatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, M5S 1A8, Canada;5. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
Abstract:Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5–10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET proto-oncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A rs1800858], G691S rs1799939], L769L rs1800861], S836S rs1800862], S904S rs1800863], and IVS1-126G>T rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号